We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

SUGENTECH INC.

SUGENTECH INC. develops, manufactures, and markets personal point-of-care testing (POCT) products, mobile healthcare ... read more Featured Products: More products

Download Mobile App





Korea’s Sugentech Granted FDA EUA for Gold Nanoparticle-Based Immunochromatographic COVID-19 Test

By LabMedica International staff writers
Posted on 09 Sep 2020
Sugentech, Inc. More...
(Daejeon, Korea) has been granted Emergency Use Authorization by the US Food and Drug Administration for the company’s SGTi-flex COVID-19 IgG which is designed to detect immunoglobulin G antibodies against SARS-CoV-2 in serum, plasma, and venous whole blood.

The SGTi-flex COVID-19 IgG from Sugentech is a gold nanoparticle-based immunochromatographic test kit for the qualitative determination of COVID-19’s IgG antibodies in human whole blood (finger prick or venous), serum or plasma. The kits are accurate and easy to use and the results can be observed with the naked eye within 10 minutes. The test detects the presence of antibodies, which are specific proteins made in response to infections. Antibodies can be found in the blood of those who are tested after infection. The antibodies detected by the test indicate that a person had an immune response to COVID-19, whether the symptoms developed from the infection or the infection was asymptomatic.

Antibody test results are important in detecting infections with few or no symptoms. As there is no medicine or vaccine, the best way to combat this infection is isolation. A significant number of infected people do not have any symptoms, making quick diagnosis very important. The SGTi-flex COVID-19 IgM/IgG enables healthcare workers to identify people with infection and isolate the ones without any symptoms but are suspected of having COVID-19.




Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Portable Electronic Pipette
Mini 96
Autoimmune Disease Diagnostic
Chorus ds-DNA-G
New
Rapid Molecular Testing Device
FlashDetect Flash10
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: AiPlex VAS for the MosaiQ platform is designed to help reduce time-to-diagnosis for patients with autoimmune vasculitis (Photo courtesy of AliveDx)

Novel Multiplex Assay Supports Diagnosis of Autoimmune Vasculitis

Autoimmune vasculitis and related conditions are difficult to diagnose quickly and accurately, often requiring multiple tests to confirm the presence of specific autoantibodies. Traditional methods can... Read more

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Technology

view channel
Image: The sensor can help diagnose diabetes and prediabetes on-site in a few minutes using just a breath sample (Photo courtesy of Larry Cheng/Penn State)

Graphene-Based Sensor Uses Breath Sample to Identify Diabetes and Prediabetes in Minutes

About 37 million U.S. adults live with diabetes, and one in five is unaware of their condition. Diagnosing diabetes often requires blood draws or lab visits, which are costly and inconvenient.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.